FDA approves orforglipron, first GLP-1 pill without food or water restrictions
Eli Lilly's daily oral small-molecule GLP-1 receptor agonist can be taken at any time, unlike oral semaglutide's fasting requirement.
DO
By Daniel Okafor · Regulatory Correspondent
Apr 1 03:00 ETSource: Pharmacy Times
The wire
- 01The FDA approved orforglipron, a once-daily GLP-1 pill that carries no timing, food or water restrictions on administration.
- 02An oral option without dosing restrictions changes the counseling burden for pharmacists and gives telehealth prescribers an alternative to injectables and oral semaglutide.
- 03Approved indication wording, pricing and launch supply were not detailed in the report; prescribers should confirm details against the final label.
From the source
Read at pharmacytimes.comFDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions
